Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TP53RK binding protein (TPRKB) is a protein-coding gene encoding a subunit of the highly conserved EKC/KEOPS protein complex, which is necessary for a key tRNA modification—formation of threonylcarbamoyladenosine (t6A) at position 37 in tRNA molecules that decode ANN codons. TPRKB acts as an allosteric effector within the complex, regulating its t6A modification activity but is not strictly required for the modification itself. It facilitates protein kinase binding and contributes to processes involved in tRNA processing and potentially RNA stability and translation. Mutations in TPRKB cause autosomal recessive Galloway-Mowat syndrome 5, a severe developmental disorder. No specific drugs or clinical interventions are known to act directly via TPRKB.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TP53RK binding protein (TPRKB).